Twenty years of expert allergy and immunology care for children and adults across South Florida. Advanced diagnostics, personalized treatment, lasting results.
Board-certified in Allergy & Immunology and Internal Medicine, with fellowship training from NewYork-Presbyterian / Weill Cornell Medical Center.
Dr. Fatteh has more than twenty years of experience caring for both children and adults in South Florida, helping patients manage complex allergic conditions and improve long-term respiratory health.
She is also involved in medical education affiliated with Nova Southeastern University, committed to helping patients understand their conditions and providing modern treatments that allow them to live healthier, symptom-free lives.
Over two decades, advances in immunology have revealed that many chronic diseases—asthma, eczema, sinusitis, food allergies—share common immune pathways, enabling a new era of targeted treatment.
In many patients, the immune system produces excessive signals that lead to airway inflammation, mucus production, and airway narrowing. This is not just a breathing problem—it is fundamentally an immune system problem requiring targeted therapy.
Immunoglobulin E — the antibody produced in response to allergens such as pollen, dust mites, mold, or animal dander.
A biologic medication that interrupts the IgE pathway—reducing allergic inflammation and lowering the frequency of asthma attacks in patients with moderate to severe allergic asthma.
Unlike medications that only relieve symptoms, allergen immunotherapy rewrites the immune system's response—one of the only treatments that can modify the natural course of allergic disease.
Allergen immunotherapy exposes the immune system to very small, controlled amounts of the allergen over time, allowing it to develop tolerance and shift away from an allergic response. Over time, several important immunologic changes occur.
For many patients, the improvements continue for years after the course of treatment is complete—making allergen immunotherapy a true disease-modifying therapy, not just symptom management.
Strict avoidance was once the only option. Advances in immunology have led to oral immunotherapy—gradually increasing the body's tolerance to certain foods under careful medical supervision.
OIT administers very small, carefully measured amounts of the food allergen, incrementally increased over time. As treatment progresses, the immune system undergoes measurable changes that reduce its reactivity.
Cells involved in allergic reactions become progressively less reactive to the food allergen.
IgE response to the food allergen diminishes as tolerance builds over time.
Increased production of antibodies that intercept the allergen before a reaction occurs.
The immune system learns to coexist with the allergen without overreacting.
OIT is a relatively new and evolving area of allergy care. Not every patient is a candidate. Treatment must be carefully individualized and monitored by experienced allergy specialists.
Discuss with our team →Meet the characters of Mast Park — a friendly comic world where pollen, mast cells, and IgE come to life to help kids understand what's happening inside their bodies.
IgE and friends live peacefully in Mast Park until pollen arrives and stirs up the mast cell, triggering the allergic cascade. With the help of a special book on Immunotherapy, IgE and the mast cell learn to work together — just like real allergy treatment does.
Created to help young patients understand their immune system — and why treatment works.
Dr. Fatteh has contributed to clinical and translational research with publications focusing on allergy diagnostics, immunologic diseases, and therapeutic interventions.
Examined variability in allergy skin testing practices and emphasized the need for standardized protocols to improve diagnostic accuracy and patient outcomes.
Evaluated dosing strategies for subcutaneous immunoglobulin therapy used to treat patients with primary immunodeficiency disorders.
Described a desensitization protocol enabling safe antiviral therapy in a patient with a documented medication allergy following bone marrow transplant.
Evaluated diagnostic characteristics and treatment outcomes in patients with hereditary angioedema with normal C1 inhibitor levels.
Multi-center clinical analysis examining the diagnostic role of C1-esterase inhibitor therapy in patients with suspected hereditary angioedema.
Dr. Fatteh has been actively involved in professional leadership, medical education, and physician organizations at the local, national, and international levels.
Schedule a consultation with Dr. Fatteh and take the first step toward comprehensive, personalized allergy and immunology care.